Average Co-Inventor Count = 5.89
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Aktiengesellschaft (52 from 1,384 patents)
2. Bayer Schering Pharma Ag (6 from 192 patents)
3. Novartis Ag (5 from 3,923 patents)
4. A/s Ferrosan (2 from 41 patents)
5. Other (1 from 832,680 patents)
6. Shering Ag (1 from 7 patents)
7. Scherling Ag (1 from 1 patent)
8. Schering Aktienegesellschaft (1 from 1 patent)
9. Schering Aktiengeseellschaft (1 from 1 patent)
10. Scnering Aktiengesellschaft (1 from 1 patent)
11. Bayer Pharma Aktiengesellschaft (378 patents)
66 patents:
1. 7906533 - Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
2. 7902229 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
3. 7850948 - Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
4. 7615565 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
5. 7572794 - Anthranilamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors
6. 7517894 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
7. 7479491 - Azanthranylalkyl and -cycloalkyl amides and their use as VEGF receptor inhibitors
8. 7459470 - N-oxide anthranylamide derivatives and their use as medicaments
9. 7429592 - Cyanoanthranilamide derivatives and the use thereof as medicaments
10. 7427390 - Radiohalogenated benzamide derivatives and their use in tumor diagnosis and tumor therapy
11. 7202260 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridones
12. 7148357 - VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
13. 7122547 - Anthranilic acid amides and the use thereof as medicaments
14. 7081468 - Ortho-substituted anthranilic acid amides and their use as medicaments
15. 7012081 - Anthranyl amides and their use as medicaments